Trial intelligence / Profile preview

RFA and HAI Chemotherapy for Colorectal Liver Metastases

NCT00004142Phase 2Completed

Sponsor
University of Texas MD Anderson Cancer Center
Start
Aug 1998
Primary completion
Dec 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of floxuridine, fluorouracil in colorectal cancer (CRC), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 1998; status: completed.

02

Drugs

floxuridinefluorouracil
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00004142.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004142.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call